Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - M&A
 More »

  • Takeover Targets: Who Is First on the List?
    Cowen & Co. in its quarterly biotech report, titled "Where Has All The Biotech M&A Gone?" ... Cowen & Co. in its quarterly biotech report, titled "Where Has All The Biotech M&A Gone?" ...
    9-24-2013
  • As Big Deals Resurface, Who's Next to the Altar?
    Amgen-Onyx, Perrigo-Elan warm an M&A space that had been chilled by an IPO revival. Amgen's planned acquisition of Onyx Pharmaceuticals was a reminder of how quiet the M&A market ...
    9-9-2013
  • Breckenridge Buys ANDAs for $30M from Pernix' Cypress Unit
    $5.9 million during Q2, compared with an $0.9 million net loss a year earlier, on net sales that nearly doubled from Q2 2012 to $20.6 million, reflecting M&A activity since then. ...
    8-9-2013
  • Beckman Coulter Life Sciences Acquires ReaMetrix' Flow Cytometry...
    more than $8 billion of potential M&A capacity available through 2014 to expand and strengthen our strategic growth platforms," Culp said, according to a transcript by Morningstar. ...
    8-2-2013
  • M&A Doubleheader: Two Ailing Companies Bought Out
    Two ailing firms have been scooped in M&A deals announced this week. First, through a ... Labs is acquiring Allon Therapeutics. M&A Doubleheader: Spectrum Buys Talon, Paladin ...
    7-17-2013
  • Outsourcing Asset Management
    ... can facilitate mergers and acquisitions (M&A) by allowing managers to easily analyze ... reported expecting M&A activity to impact their organization in the next three years." ...
    7-1-2013
  • Don't Let Fraud Ruin Your Deal
    When It Comes to International Life Sciences M&A, Careful Preparation Is Key Mark C. ... As we all know, the life sciences industry has seen remarkable growth in M&A activity over ...
    6-1-2013
  • E&Y: Biotechs Must Walk the Walk on Drug Value
    ... Pharma venture funds and other sources have begun filling the gap left when VCs retrenched on investment, Giovannetti said. M&A activity rises: The total value of mergers and ...
    4-22-2013
  • Clock Ticking in Elan Takeover Battle
    ... saying it expected to complete "due diligence" reviews in 20 days, and noting that its M&A advisors were J.P. Morgan, Bank of America's Merrill Lynch, and Groton. "$1.1+ [billion] ...
    4-3-2013
  • Biopharmas Cooling to Licensing Deals as Patent Cliff Fears Ease
    Also declining last year were M&A deals, which fell to $42.6 billion in 180 deals, or 24% ... One area where licensing and M&A activity could increase this year, Urquhart said, is ...
    3-28-2013
  • Biggest Biotech Trends of 2012
    ... M&A Deals: The Year Without a Blockbuster The year saw no blockbuster like last year's Sanofi $20.1 billion purchase of Genzyme. M&A activity fell 35% over 2011, according to the ...
    1-15-2013
  • Top 25 M&A Deals of 2012
    Whether you jump for joy or quiver in terror at the thought of another M&A, you still want ... shares before the announcement of an M&A deal. #25. YM Biosciences Acquired by: ...
    1-4-2013
  • 7 Biotech Trends for the Coming Year
    ... least a 20% jump in the dollar volume of M&A activity in 2013 compared with 2012, driven ... Deloitte offered another key driver of M&A activity in its 2013 Global Life Sciences ...
    1-3-2013
  • LGC Buys Bioanalytical Sciences Business from Quotient Bioresearch
    This transaction follows the sale two years ago by Quotient to LGC of HFL Sport Science, which is also based at the Fordham site. LGC has been busy with M&A activity lately. Last ...
    1-2-2013
  • Necessary Liaisons: CROs Gain Clout & Responsibility
    ... Is M&A Frenzy Slowing? Many observers say the CRO merger and acquisition activity is ... own company (PharmaNet/i3) is itself an M&A product created to build a CRO with the ...
    1-1-2013

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Balancing Family and Career for Women Ph.D.s

Which changes made to academic culture are most likely to encourage women researchers to stay?

Suggest a Poll